CN101073519B - 眼内插入用晶状体的插入器具 - Google Patents
眼内插入用晶状体的插入器具 Download PDFInfo
- Publication number
- CN101073519B CN101073519B CN 200710105014 CN200710105014A CN101073519B CN 101073519 B CN101073519 B CN 101073519B CN 200710105014 CN200710105014 CN 200710105014 CN 200710105014 A CN200710105014 A CN 200710105014A CN 101073519 B CN101073519 B CN 101073519B
- Authority
- CN
- China
- Prior art keywords
- crystalline lens
- mentioned
- section
- ophthalmic
- utensil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003780 insertion Methods 0.000 title claims abstract description 117
- 230000037431 insertion Effects 0.000 title claims abstract description 117
- 210000000695 crystalline len Anatomy 0.000 claims description 227
- 210000005252 bulbus oculi Anatomy 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 21
- 238000006073 displacement reaction Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000007788 liquid Substances 0.000 abstract description 82
- 230000002093 peripheral effect Effects 0.000 abstract description 34
- 230000004410 intraocular pressure Effects 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 23
- 238000007789 sealing Methods 0.000 description 16
- 239000003190 viscoelastic substance Substances 0.000 description 13
- 208000005189 Embolism Diseases 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 208000001435 Thromboembolism Diseases 0.000 description 9
- 210000002159 anterior chamber Anatomy 0.000 description 8
- 210000001508 eye Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000002788 crimping Methods 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- 241000237970 Conus <genus> Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000004127 vitreous body Anatomy 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- -1 carboxyethyl Chemical group 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940059939 kayexalate Drugs 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006139561A JP2007307168A (ja) | 2006-05-18 | 2006-05-18 | 眼内挿入用レンズの挿入器具 |
| JP2006139560 | 2006-05-18 | ||
| JP2006-139561 | 2006-05-18 | ||
| JP2006139560 | 2006-05-18 | ||
| JP2006139561 | 2006-05-18 | ||
| JP2006-139560 | 2006-05-18 | ||
| JP2006-155051 | 2006-06-02 | ||
| JP2006155051A JP4586173B2 (ja) | 2006-06-02 | 2006-06-02 | 眼内挿入用レンズの挿入器具 |
| JP2006155051 | 2006-06-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101073519A CN101073519A (zh) | 2007-11-21 |
| CN101073519B true CN101073519B (zh) | 2013-03-20 |
Family
ID=38974904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200710105014 Expired - Fee Related CN101073519B (zh) | 2006-05-18 | 2007-05-18 | 眼内插入用晶状体的插入器具 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5160812B2 (enExample) |
| CN (1) | CN101073519B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8894664B2 (en) | 2008-02-07 | 2014-11-25 | Novartis Ag | Lens delivery system cartridge |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100057093A1 (en) * | 2007-02-08 | 2010-03-04 | Takeshi Ide | Injector for eye |
| US8747465B2 (en) | 2007-05-30 | 2014-06-10 | Hoya Corporation | Intraocular lens insertion device |
| US20080312661A1 (en) * | 2007-06-12 | 2008-12-18 | Downer David A | Lens Injector Lumen Tip for Wound Assisted Delivery |
| JP5269488B2 (ja) * | 2008-06-02 | 2013-08-21 | 株式会社ニデック | 眼内レンズ挿入器具 |
| JP5388094B2 (ja) * | 2008-09-12 | 2014-01-15 | スター・ジャパン合同会社 | 眼内挿入用レンズの挿入器具及び眼内挿入用レンズ内装型挿入器具 |
| JP5570265B2 (ja) * | 2010-03-26 | 2014-08-13 | 株式会社ニデック | 眼内レンズ挿入器具 |
| EP2608739B1 (en) * | 2010-08-24 | 2021-08-11 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens insertion system |
| CN102283741A (zh) * | 2011-07-14 | 2011-12-21 | 广州卫视博生物科技有限公司 | 折叠式人工玻璃体推注器 |
| CN104379093B (zh) * | 2012-04-20 | 2016-07-06 | 斯塔尔外科有限公司 | 适用于眼内晶状体的预加载注射器 |
| US12127934B2 (en) | 2014-09-09 | 2024-10-29 | Staar Surgical Company | Method of Providing Modified Monovision to a Subject with a First Lens and a Second Lens |
| CA2960503C (en) | 2014-09-09 | 2022-01-25 | Staar Surgical Company | Ophthalmic implants with extended depth of field and enhanced distance visual acuity |
| US10588780B2 (en) * | 2015-03-04 | 2020-03-17 | Alcon Inc. | Intraocular lens injector |
| JP6590947B2 (ja) * | 2015-04-19 | 2019-10-16 | アトリオン・コーポレイションＡｔｒｉｏｎ Ｃｏｒｐｏｒａｔｉｏｎ | ばね動力／液圧操作式眼内レンズ挿入器具 |
| WO2017065007A1 (ja) | 2015-10-16 | 2017-04-20 | 興和株式会社 | 眼内レンズ挿入システム、眼内レンズ挿入器具およびチューブ |
| BR112018068184B1 (pt) | 2016-03-09 | 2023-02-14 | Staar Surgical Company | Lente configurada para implantação em um olho de um ser humano |
| JP6998303B2 (ja) | 2016-06-28 | 2022-01-18 | Hoya株式会社 | 眼内レンズ挿入器 |
| US11000367B2 (en) | 2017-01-13 | 2021-05-11 | Alcon Inc. | Intraocular lens injector |
| US10568735B2 (en) | 2017-01-13 | 2020-02-25 | Alcon Inc. | Intraocular lens injector |
| JP7162443B2 (ja) | 2018-05-16 | 2022-10-28 | Hoya株式会社 | 容器付き眼内リング挿入器 |
| JP7162445B2 (ja) | 2018-05-25 | 2022-10-28 | Hoya株式会社 | 眼内レンズ挿入器 |
| AU2019301284B2 (en) * | 2018-07-10 | 2024-08-29 | Alcon Inc. | Intraocular lens injector |
| EP3837571B1 (en) | 2018-08-17 | 2023-08-02 | Staar Surgical Company | Polymeric composition exhibiting nanogradient of refractive index |
| JP7327956B2 (ja) | 2019-03-13 | 2023-08-16 | Hoya株式会社 | 眼内レンズ挿入器具 |
| CN118338869A (zh) | 2021-10-04 | 2024-07-12 | 斯塔尔外科有限公司 | 用可调谐的光学器件矫正视力的眼科植入物及其制造和使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2000287A1 (en) * | 1988-10-07 | 1990-04-07 | David C. Buboltz | Intraocular lens insertion instrument |
| JPH0779826B2 (ja) * | 1991-06-14 | 1995-08-30 | キヤノンスター株式会社 | 眼内レンズの移植器具 |
| WO2000040175A1 (en) * | 1999-01-06 | 2000-07-13 | Tekia, Inc. | Apparatus for insertion of an intraocular lens |
| FR2822055B1 (fr) * | 2001-03-16 | 2003-09-12 | Lab Contactologie Appl Lca | Injecteur pour lentille intraoculaire |
| JP4310051B2 (ja) * | 2001-03-29 | 2009-08-05 | 株式会社ニデック | 眼内レンズ挿入器具 |
| JP4068479B2 (ja) * | 2003-02-28 | 2008-03-26 | 株式会社ニデック | 眼内レンズ挿入器具 |
| JP2006006817A (ja) * | 2004-06-29 | 2006-01-12 | Canon Star Kk | 眼内挿入用レンズの挿入器具 |
| CA2588199C (en) * | 2004-11-30 | 2010-09-07 | Baush & Lomb Incorporated | Two stage plunger for intraocular lens injector |
-
2007
- 2007-05-18 CN CN 200710105014 patent/CN101073519B/zh not_active Expired - Fee Related
- 2007-05-18 JP JP2007132538A patent/JP5160812B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8894664B2 (en) | 2008-02-07 | 2014-11-25 | Novartis Ag | Lens delivery system cartridge |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101073519A (zh) | 2007-11-21 |
| JP5160812B2 (ja) | 2013-03-13 |
| JP2007330783A (ja) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101073519B (zh) | 眼内插入用晶状体的插入器具 | |
| EP1857076B1 (en) | Insertion device for intraocular lens | |
| AU2021269283B2 (en) | Accommodating intraocular lenses and methods of manufacturing | |
| CN104797214B (zh) | 人工晶体，尤其是睫状肌人工晶体 | |
| US9820849B2 (en) | Intraocular lens, in particular capsular sac intraocular lens | |
| JP5161211B2 (ja) | 眼内挿入用レンズの挿入器具及び眼内挿入用レンズ内装型挿入器具 | |
| EP1259283B1 (fr) | Dispositif implantable d'injection de substances medicales | |
| JP2007307168A (ja) | 眼内挿入用レンズの挿入器具 | |
| EP0203633A1 (fr) | Dispositif implantable d'injection chronique d'une substance, notamment thérapeutique | |
| CN1985781B (zh) | 眼内插入用晶状体的插入器具 | |
| EP2412337A1 (fr) | Implant intraoculaire a éléments d'accrochage. | |
| FR2997624A1 (fr) | Implant intraoculaire pseudophake de rhexis | |
| JP4586173B2 (ja) | 眼内挿入用レンズの挿入器具 | |
| JP4871024B2 (ja) | 眼内挿入用レンズの挿入器具 | |
| CA3187022A1 (en) | Outer needle assembly | |
| HK1110496A (en) | Insertion device for intraocular lens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1110496 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1110496 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130320 Termination date: 20150518 |
|
| EXPY | Termination of patent right or utility model |